On March 17, 2026, the Hong Kong Biotechnology Organization (HKBIO) in partnership with the Netherlands Consulate General in Hong Kong and Macau successfully concluded a high-level closed-door biotech exchange. This event brought together representatives from the Dutch Ministry of Economic Affairs, Ministry of Health, Welfare and Sport, Netherlands Foreign Investment Agency, and other government bodies, alongside leading industry parks such as Pivot Park, top research institutions including Radboud University Medical Center, University of Groningen, and TNO, as well as innovative biotech companies like Constellate Proteomics, and AVIGI Therapeutics. Over 50 members of Hong Kong’s biotech community participated, united by a shared goal: to foster innovation, deepen industry collaboration, and unlock new business opportunities.
Group Photo of the Netherland Delegation and HKBIO members
The event began with opening remarks from Maurits Ter Kuile, Consul General of the Netherlands in Hong Kong and Macau, noted Hong Kong’s role as a super-connector linking the Chinese mainland and international markets in research, capital and policy, a unique bridge for Dutch enterprises to explore China.
Maurits Ter Kuile, Consul General of the Netherlands in Hong Kong and Macau to the left and Hans Schikan, Board Member of Health Holland, and Head of the Netherlands Delegation to the right
Hans Schikan, Board Member of Health Holland, and Head of the Netherlands Delegation, expressed great admiration for China’s unprecedented biotech development speed and innovation pace.
HKBIO Chairman Prof. Albert Cheung-Hoi Yu, PhD, JP
As the organizer, HKBIO Chairman Prof. Albert Cheung-Hoi Yu, PhD, JP, stated Hong Kong’s international vision makes it an ideal base for cross-border biotech cooperation and commercialization, with huge cooperation potential with the Netherlands in basic research, clinical translation and venture capital.
Hans Schikan, Board Member of Health Holland, and Head of the Netherlands Delegation to the left is meeting HKBIO Chairman Prof. Albert Cheung-Hoi Yu, PhD, JP to the right
Members from the Dutch delegation are networking with HKBIO members
During the free-flowing networking session, participants engaged in in-depth discussions on technology transfer, market expansion, supply chain synergy, and cross-border collaboration. This event has laid a solid foundation for future innovation, industry growth, and commercial opportunities between Hong Kong and the Netherlands.
This bilateral exchange is a key milestone in HKBIO’s mission to build a global biotech innovation network. As we gear up for BIOHK 2026 this September, we invite more international biotech players to join us. We are committed to streamlining policy, cutting-edge research, and capital markets into a comprehensive ecosystem—making Asia’s most influential biotech gathering.
Rooted in Hong Kong, connected to the world, BIOHK 2026 awaits your participation. Join us to explore collaboration opportunities, showcase innovation, and shape the future of biotech. Registration, partnership, and participation details are coming soon—stay tuned!
